Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 Apr. 13];1(3.1):s32. Available from: https://skin.dermsquared.com/skin/article/view/117